Is Agilent Technologies, Inc. overvalued or undervalued?

As of 28 May 2025, Agilent Technologies, Inc. has moved from an attractive to a fair valuation grade. The company is currently fairly valued based on its financial metrics. The P/E ratio stands at 25, while the EV to EBITDA ratio is 18.73, and the ROE is 21.31%.
In comparison to its peers, Abbott Laboratories has a more attractive P/E ratio of 19.12, while Thermo Fisher Scientific, Inc. also shows a favorable EV to EBITDA ratio of 17.94. Notably, Agilent's recent stock performance has lagged behind the S&P 500, with a year-to-date return of -13.56% compared to the S&P 500's 2.44%, reinforcing the notion that the stock may not be positioned for significant upside in the near term.